The White House has proposed good and bad ideas to reduce drug costs. Among the better ones is a reform of the obscure 340B ...

A judge upholds Maine's contract pharmacy law, rejecting drugmakers' claims that it conflicts with federal rules governing ...

On Wednesday, health care providers and drug manufacturers hotly debated legislation looking to ensure hospitals can purchase ...

A federal judge on Tuesday refused to block Maine from enforcing a new state law requiring drugmakers to offer discounts on ...

The core problem in 340B runs deeper than poor oversight. The law requires steep discounts for purchased drugs but does not specify that the savings should be passed on to patients and insurance ...

The following information was released by the National Pharmaceutical Council:. Washington, D.C. The 340 B Drug Pricing Program has grown immensely since the Affordable Care Act was passed in 2010.

The pilot is a significant departure from the current model, which gives hospitals upfront discounts for some drugs. The program has proved a flash point between drugmakers and providers, as ...

An obscure, supposedly free federal program is blowing a hole in state budgets – by depriving state governments of billions in corporate tax revenue and inflating costs for their public employee ...

HRSA is piloting a 340B rebate model similar to one that it just fought against. As the agency dips its toes into the 340B debate, hospital groups express concerns about the potential for cash flow ...

As a permanent ostomate, I am all too familiar with the complexities of the American healthcare system. I’ve been insured, underinsured, and uninsured, often forced to ration medications and avoid ...